Heart Test Laboratories, Inc.

As of June 11, 2025, Heart Test Laboratories, Inc. has a mildly bullish trend, supported by weekly MACD and KST indicators, while the monthly RSI remains bullish, indicating a positive but cautious outlook.

Heart Test Laboratories, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $4.02 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -465.37%.

As of Jun 18, Heart Test Laboratories, Inc. has a market capitalization of 4.02 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -8.52 million over the latest four quarters. The company reported shareholder's funds of 7.32 million and total assets of 9.50 million as of Apr 24.